These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 139479)

  • 1. Antibody to hepatitis A antigen in institutionalized mentally retarded patients.
    Szmuness W; Purcell RH; Dienstag JL; Stevens CE
    JAMA; 1977 Apr; 237(16):1702-5. PubMed ID: 139479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK; Perry E; Cleary TE
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of hepatitis B infection in institutionalized mentally retarded clients.
    Lohiya S; Lohiya G; Caires S
    Am J Public Health; 1986 Jul; 76(7):799-802. PubMed ID: 2940879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.
    McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK
    Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID; Dimitrakakis M; Sharma DL
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatitis B virus in an institution for mentally retarded persons.
    Madden DL; Dietzman DE; Matthew EB; Sever JL; Lander JJ; Purcell RH; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):369-75. PubMed ID: 129004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis A in an institution for the mentally retarded in an intermediate endemicity area: influence of age length of institutionalization.
    Gil A; González A; Dal-Ré R; Dominguez V; Ortega P; Barrio JL; Aguilar L
    J Infect; 1999 Mar; 38(2):120-3. PubMed ID: 10342653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patients.
    Cooper BW; Klimek JJ; Upadhyaya A; Devine S
    Am J Infect Control; 1986 Oct; 14(5):204-8. PubMed ID: 3641542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antibody to the hepatitis A virus in a large institution for the mentally retarded.
    Lehmann NI; Sharma DL; Gust ID
    J Med Virol; 1978; 2(4):335-9. PubMed ID: 215714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of hepatitis infection in an institution for the mentally retarded.
    Williamson HG; Lehmann NI; Dimitrakakis M; Sharma DL; Gust ID
    Aust N Z J Med; 1982 Feb; 12(1):30-4. PubMed ID: 6952837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and distribution of hemagglutinating antibody against the hepatitis B antigen in institutionalized populations.
    Szmuness W; Prince AM; Etling GF; Pick R
    J Infect Dis; 1972 Nov; 126(5):498-506. PubMed ID: 4268554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis B (HBV) and C (HBC) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome].
    Findor JA; Sordá JA; Rey J; Fernández J; Kohan A; Díaz Lestrem M
    G E N; 1992; 46(3):208-12. PubMed ID: 1340826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B in a hospital for the mentally subnormal in southern England.
    Kingham JG; McGuire M; Paine DH; Wright R
    Br Med J; 1978 Aug; 2(6137):594-6. PubMed ID: 151573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunogenicity of the vaccine against the HBV in the mentally retarded].
    Cobo Soriano J; Gil Miguel A; Rey Calero J; Herrazo Cabrera R; Martín Hernández D
    Aten Primaria; 1991; 8(7):536, 538-40, 542. PubMed ID: 1836394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rational use of serological methods in diagnosis of virus hepatitis A and B (author's transl)].
    Seelig R; Seelig HP
    Immun Infekt; 1982 Jan; 10(1):15-22. PubMed ID: 7040207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.